Search all medical codes

Injection, burosumab-twza 1 mg

HCPCS code

Medical Policies and Guidelines for Injection, burosumab-twza 1 mg

Related policies from health plans

Crysvita (burosumab-twza)
CRYSVITA, Burosumab-twza

Similar Codes


ICD10CM codes

Z30.42 - Encounter for surveillance of injectable contraceptive
Z30.013 - Encounter for initial prescription of injectable contraceptive
T80.90XA - Unspecified complication following infusion and therapeutic injection, initial encounter
T80.90 - Unspecified complication following infusion and therapeutic injection
Y64.1 - Contaminated medical or biological substance, injected or used for immunization
T83.724A - Exposure of implanted ureteral bulking agent into ureter, initial encounter
Z03.823 - Encounter for observation for suspected inserted (injected) foreign body ruled out
T80.90XD - Unspecified complication following infusion and therapeutic injection, subsequent encounter
T83.724 - Exposure of implanted ureteral bulking agent into ureter
Z29.1 - Encounter for prophylactic immunotherapy

HCPCS codes

J0584 - Injection, burosumab-twza 1 mg
J0179 - Injection, brolucizumab-dbll, 1 mg
J0594 - injection, busulfan, 1 mg
J0583 - Injection, bivalirudin, 1 mg
J0897 - Injection, denosumab, 1 mg
J3262 - Injection, tocilizumab, 1 mg
J1628 - Injection, guselkumab, 1 mg
J9306 - Injection, pertuzumab, 1 mg
J3245 - Injection, tildrakizumab, 1 mg
J9271 - Injection, pembrolizumab, 1 mg

CPT4 codes

68200 - Subconjunctival injection
90284 - Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
96372 - Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intr
80348 - Buprenorphine
20552 - Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)
90396 - Varicella-zoster immune globulin, human, for intramuscular use
90389 - Tetanus immune globulin (TIg), human, for intramuscular use
96379 - Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusio
80280 - Vedolizumab
11951 - Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc